跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,300 条关于
“SCA2”
全部
1,300
临床试验
1,259
药物
13
机构
0
资讯
28
3个月前
MRI Biomarkers Revolutionize Clinical Trial Design for Hereditary Ataxias
8个月前
Sarepta Therapeutics Submits Clinical Trial Application for SRP-1005 Huntington's Disease Treatment
11个月前
Sarepta Advances SRP-1003 siRNA Therapy for Myotonic Dystrophy Type 1 with Positive Safety Review
去年
Arrowhead Seeks FDA Approval for Plozasiran in Familial Chylomicronemia Syndrome
去年
Sarepta Therapeutics and Arrowhead Pharmaceuticals Announce RNAi Collaboration to Treat Rare Genetic Diseases
去年
Arrowhead Pharmaceuticals Receives $100 Million Milestone Payment for ARO-DM1 Myotonic Dystrophy Treatment
去年
Solaxa Advances SLX-100 to Phase 3 Trial for Rare Spinocerebellar Ataxia Type 27B
2个月前
REPROCELL Submits Application for Stem Cell Therapy Stemchymal in Japan for Spinocerebellar Ataxia SCA3 and SCA6
2年前
SELECT-AV: Self-Expandable Valves Show Non-Inferiority to Balloon-Expandable in TAVR
去年
Base and Prime Editing Scan EGFR Variants for Drug Response
第 1 页,共 3 页
上一页
下一页